- Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
- Study from NCPA sheds new light on med synchronization programs
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- Ensuring access to chronic pain medications
- New York's online database of drug prescriptions curtailing 'doctor shopping'
BRISTOL, Tenn. — Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.
The two drug makers announced Tuesday the submission for Acurox (oxycodone hydrochloride), an immediate-release tablet for relief of moderate to severe pain.
The tablets use Acura’s aversion technology, designed to deter abuse of the drug by dissolving or crushing the pills.